American Biotechnology Firm Make Progress In Finding HIV Cure
This is our top story of the day, 28 May 2021 as multiple reports have it that American Gene Technologies, a biotechnology company based in Maryland, United State Of America has taken a monumental step toward progress in finding a cure for HIV.
This came as good news to the world at large and gainfully can progress to be a lifesaver to Africans as a continent
In Africa, people attitudes toward preventive measures on HIV is dropping daily, people are no longer afraid of it, lately, a high percentage of single men and women now hate using a condom during sexual intercourse thereby daggering themselves on contracting HIV, so when will say this story ‘American Biotechnology Firm Make Progress In Finding HIV Cure’ is our top story of the day, we hope you agree with us

The American Biotechnology firm made the announcement this week that the first participant of Phase 1 clinical trial was infused with its cell and gene therapy product, AGT103-T, on May 19. “
This is a huge milestone for the company. There’s still a lot of work to do, but this is an inflection point in the history of our attempt on HIV,” said AGT CEO Jeff Galvin.
The United Nations estimates that there were approximately 38 million people around the world living with HIV in 2019, and roughly 67 percent or 25.8 million of these cases were in Africa, where there is an epidemic.
And is scarier this day across Africa, as the saying goes, HIV AIDs no they show for face and the government awareness services are dropping, people attitudes toward preventive measured establish to cub HIV AIDS is dropping drastically, High percentage of African single men and women no longer condomize during sexual intercourse, these and that are reasons why this story is our top story of the week
The report has it that about 1.1 million people in the United States are living with HIV. This is the first-in-human study for AGT103-T which is a genetically modified cell product made from a person’s cells.
The process finds used in curing HIV by the American Biotechnology firm consists of removing HIV T-cells, modifying them, and putting them back in with slight changes that make them impermeable to HIV thereby curing t permanently
The company’s innovative process focuses on repairing the major immune system damage caused by HIV. That’s is our top story today, though the findings and cure are still developing